Takeda Pharmaceutical Company Limited A
PESTEL Analysis
1. What is the history of Takeda Pharmaceutical Company Limited A, and how has it evolved? Takeda Pharmaceutical Company Limited A has been around since 1914 when it was founded by Takeo Nakanishi, a Japanese pharmaceutical entrepreneur. The company initially focused on the development and production of high-quality Japanese medicinal herbs and was known for its high quality and low price. In the 1950s and 1960s, Takeda became a leading
Evaluation of Alternatives
In the current healthcare market where the medical industry is facing a huge number of threats, Takeda Pharmaceutical Company Limited A is poised to emerge as the next major company, offering its patients and doctors a host of life-saving drugs in the future. As the first Japanese pharmaceutical company to gain approval from the US Food and Drug Administration (FDA), this company holds a tremendous potential. The first drug, TAKSEVU™ (Taxotere®) was approved in
Financial Analysis
– The company has a strong brand portfolio consisting of major drugs like Avandia, Sutherland, Revatio, and Xalatan. – Takeda has a long history of R&D and innovation, spanning from 1904 to 2012 with an investment of ¥379 billion in R&D (2012). Takeda continues to lead the development and marketing of drugs, particularly those for rare diseases. Clicking Here – Takeda has made strategic acquisitions to
BCG Matrix Analysis
In September 2012, the Japanese multinational pharmaceutical corporation Takeda Pharmaceutical Company Limited A, (Takeda) announced a deal to acquire Medimmune LLC, the US-based vaccines unit of the US-based Immunex Corporation, and Immunicon S.A, a privately-owned Belgian company focused on the development of immune-based therapies and vaccines. Takeda plans to spend around $4 billion for this acquisition, comprising
Marketing Plan
I had recently completed a case study on Takeda Pharmaceutical Company Limited A, one of the biggest pharmaceutical companies globally. I have been researching on this company for almost 2 years now, and the process of writing this case study is almost completed. Takeda is a Japanese pharmaceutical company founded in 1950. The company’s motto is “Nihon Kyakushi Sei” which roughly translates to “Health and Peace of Mind for Japan.” The company has operations in
Alternatives
I was an analyst at a company, who had to cover Takeda Pharmaceutical Company Limited A (NYSE: TKDA) in a very intense 4-month research period, where I was tasked to research and analyze Takeda Pharmaceutical Company Limited A’s financial report, revenue, operating margin, product pipeline, and company profile in terms of its financials, market share, growth potential, competitors and regulatory framework. It took around 1,500 hours of hard work, and multiple analyst’
